Answer:
AZT is a thymidine analog
Explanation:
Azidothymidine (AZT) is an antiviral drug used for the treatment of the Human immunodeficiency virus infection (HIV/AIDS) by preventing the transmission of HIV from infected cells. AZT is capable of suppressing the activity of the enzyme reverse transcriptase of the retroviral HIV genome, which enables it to copy RNA into DNA. In infected cells, this double-stranded DNA is integrated into the host genome which is then instructed to produce identical HIV copies. AZT is a thymidine analog that is incorporated into DNA and thus interferes with DNA synthesis, thereby inhibiting cell proliferation.
Answer:
If both parents do not have sickle-cell anemia, than the possibility is low.
Explanation:
If both parents have the sickle-cell trait, their offspring has a 25 percent chance of getting sickle cell anemia and a 50 percent risk of them having sickle cell trait. Meanwhile, there is also a 25 percent chance of the child not getting it at all.
If one parent has sickle cell anemia and the other has sickle cell trait, then their offspring with have a 50 percent chance of getting sickle cell anemia and a 50 percent chance of getting a sickle cell trait.
When both parents have sickle cell anemia, their child will definitely have it.
Answer: translation can begin during transcription
Explanation: In prokaryotes there is no nucleus and no separation of these processes.
